{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:32:38Z","timestamp":1793039558729,"version":"4.5.0"},"reference-count":246,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["SZZYSM202211002"],"award-info":[{"award-number":["SZZYSM202211002"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20210324122803011"],"award-info":[{"award-number":["JCYJ20210324122803011"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81701256"],"award-info":[{"award-number":["81701256"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603671"],"award-info":[{"award-number":["81603671"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.arr.2025.102739","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T07:53:57Z","timestamp":1742630037000},"page":"102739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Fluid-based biomarkers for neurodegenerative diseases"],"prefix":"10.1016","volume":"108","author":[{"given":"Yongliang","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingling","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell K.P.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8677-8475","authenticated-orcid":false,"given":"Gautam","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkai","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2025.102739_bib1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jamaneurol.2023.3997","article-title":"Neurofilament light chain elevation and disability progression in multiple sclerosis","volume":"80","author":"Abdelhak","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib2","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00415-020-09761-z","article-title":"Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis","volume":"267","author":"Abu-Rumeileh","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/joim.13332","article-title":"Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease","volume":"290","author":"Alawode","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.arr.2025.102739_bib4","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/alz.13809","article-title":"2024 Alzheimer's disease facts and figures. Alzheimer's & dementia","volume":"20","author":"Alzheimer\u2019s Association","year":"2024","journal-title":"J. Alzheimer'S. Assoc."},{"key":"10.1016\/j.arr.2025.102739_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108462","article-title":"Urine biomarkers for Alzheimer's disease: a new opportunity for wastewater-based epidemiology?","volume":"184","author":"Armenta-Castro","year":"2024","journal-title":"Environ. Int."},{"key":"10.1016\/j.arr.2025.102739_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1459502","article-title":"Big data and artificial intelligence applied to blood and CSF fluid biomarkers in multiple sclerosis","volume":"15","author":"Arrambide","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2025.102739_bib7","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","article-title":"A multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2025.102739_bib8","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2025.102739_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020222","article-title":"Neuroinflammation is associated with GFAP and sTREM2 levels in multiple sclerosis","volume":"12","author":"Azzolini","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2025.102739_bib10","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1212\/WNL.0000000000010084","article-title":"NfL as a biomarker for neurodegeneration and survival in Parkinson disease","volume":"95","author":"B\u00e4ckstr\u00f6m","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102739_bib11","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3389\/fnins.2019.01026","article-title":"Cerebrospinal fluid and blood cytokines as biomarkers for multiple sclerosis: a systematic review and meta-analysis of 226 studies with 13,526 multiple sclerosis patients","volume":"13","author":"Bai","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2025.102739_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae268","article-title":"A microRNA diagnostic biomarker for amyotrophic lateral sclerosis","volume":"6","author":"Banack","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2025.102739_bib13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","article-title":"Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests","volume":"30","author":"Barth\u00e9lemy","year":"2024","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2025.102739_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature22038","article-title":"Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice","volume":"544","author":"Becker","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.102739_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01499-6","article-title":"Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics","volume":"11","author":"Behzadi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102739_bib16","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34642-x","article-title":"Machine learning reveals protein signatures in CSF and plasma fluids of clinical value for ALS","volume":"8","author":"Bereman","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102739_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181431","article-title":"Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis","volume":"12","author":"Bernitsas","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2025.102739_bib20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/1352458519876020","article-title":"Metabolomics in multiple sclerosis disease course and progression","volume":"26","author":"Bhargava","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.arr.2025.102739_bib21","doi-asserted-by":"crossref","first-page":"11874","DOI":"10.1002\/anie.202014898","article-title":"Single-molecule counting coupled to rapid amplification enables detection of \u03b1-synuclein aggregates in cerebrospinal fluid of parkinson's disease patients","volume":"60","author":"Bhumkar","year":"2021","journal-title":"Angew. Chem. (Int. Ed. Engl. )"},{"key":"10.1016\/j.arr.2025.102739_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063383","article-title":"Emerging biomarkers of multiple sclerosis in the blood and the CSF: a focus on neurofilaments and therapeutic considerations","volume":"23","author":"Biernacki","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.tips.2015.03.002","article-title":"Amyloid biomarkers in Alzheimer's disease","volume":"36","author":"Blennow","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146672","article-title":"Increased level of NEAT1 long non-coding RNA is detectable in peripheral blood cells of patients with Parkinson\u2019s disease","volume":"1730","author":"Boros","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2025.102739_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.14283\/jpad.2020.57","article-title":"A Systematic review on the feasibility of salivary biomarkers for Alzheimer's disease","volume":"8","author":"Bouftas","year":"2021","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.arr.2025.102739_bib27","doi-asserted-by":"crossref","first-page":"7786","DOI":"10.1038\/s41598-024-57949-4","article-title":"Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot study","volume":"14","author":"Boussamet","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102739_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000516752","article-title":"Estimated prevalence and incidence of amyotrophic lateral sclerosis and SOD1 and C9orf72 genetic variants","volume":"55","author":"Brown","year":"2021","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.arr.2025.102739_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10091353","article-title":"Role of oxidative damage in Alzheimer's disease and neurodegeneration: from pathogenic mechanisms to biomarker discovery","volume":"10","author":"Buccellato","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.arr.2025.102739_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13195-022-01133-1","article-title":"Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer's disease","volume":"14","author":"Cai","year":"2022","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102739_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2018.12.030","article-title":"\u03b1-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease","volume":"696","author":"Cao","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2025.102739_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67138-8","article-title":"Human salivary Raman fingerprint as biomarker for the diagnosis of Amyotrophic Lateral Sclerosis","volume":"10","author":"Carlomagno","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102739_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/10408363.2022.2039591","article-title":"Oligoclonal bands: clinical utility and interpretation cues","volume":"59","author":"Carta","year":"2022","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11357-019-00127-6","article-title":"Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer's disease","volume":"42","author":"Cervellati","year":"2020","journal-title":"GeroScience"},{"key":"10.1016\/j.arr.2025.102739_bib35","doi-asserted-by":"crossref","first-page":"12299","DOI":"10.18632\/aging.203064","article-title":"BACE1: from biomarker to Alzheimer's disease therapeutical target","volume":"13","author":"Cervellati","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.arr.2025.102739_bib36","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3233\/JAD-230572","article-title":"Extracellular Vesicle-Enriched miRNA-Biomarkers Show Improved Utility for Detecting Alzheimer's Disease Dementia and Medial Temporal Atrophy","volume":"99","author":"Chai","year":"2024","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2025.102739_bib37","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","article-title":"Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS","volume":"30","author":"Chatterjee","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2025.102739_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12061253","article-title":"SIMOA diagnostics on Alzheimer's disease and frontotemporal dementia","volume":"12","author":"Chatziefstathiou","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2025.102739_bib39","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/alz.12332","article-title":"Plasma P-tau181 to A\u03b242 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease","volume":"17","author":"Chong","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102739_bib40","article-title":"Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort","volume":"16","author":"Chong","year":"2024","journal-title":"Alzheimers Dement (Amst."},{"key":"10.1016\/j.arr.2025.102739_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14502","article-title":"Clinical utility of plasma p-tau217 in identifying abnormal brain amyloid burden in an Asian cohort with high prevalence of concomitant cerebrovascular disease","volume":"21","author":"Chong","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102739_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061265","article-title":"Integrated lipidomics and metabolomics analysis of tears in multiple sclerosis: an insight into diagnostic potential of lacrimal fluid","volume":"20","author":"Cicalini","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13195-019-0564-2","article-title":"CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia","volume":"11","author":"Clarke","year":"2019","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102739_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100082","article-title":"Biofluid biomarker changes following treatment with sabirnetug (ACU193) in INTERCEPT-AD, a phase 1 trial in early Alzheimer's disease","author":"Cline","year":"2025","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.arr.2025.102739_bib45","article-title":"Top-down proteomics of human saliva highlights anti-inflammatory, antioxidant, and antimicrobial defense responses in Alzheimer disease","volume":"15","author":"Contini","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2025.102739_bib46","article-title":"Potential Role of CHI3L1+\u2009astrocytes in progression in MS","volume":"8","author":"Cubas-N\u00fa\u00f1ez","year":"2021","journal-title":"Neurol. (R. ) Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102739_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12050595","article-title":"Investigation of whole and glandular saliva as a biomarker for Alzheimer's disease diagnosis","volume":"12","author":"Cui","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.arr.2025.102739_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101636","article-title":"Neurogenesis in aging and age-related neurodegenerative diseases","volume":"78","author":"Culig","year":"2022","journal-title":"Ageing Res Rev."},{"issue":"9","key":"10.1016\/j.arr.2025.102739_bib49","first-page":"S115","article-title":"Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's disease study","volume":"19","author":"Dage","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102739_bib50","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/tvst.7.6.22","article-title":"Combined targeted analysis of metabolites and proteins in tear fluid with regard to clinical applications","volume":"7","author":"Dammeier","year":"2018","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.arr.2025.102739_bib51","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","article-title":"Multi-platform proteomic analysis of Alzheimer's disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome","volume":"14","author":"Dammer","year":"2022","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102739_bib52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40035-019-0164-x","article-title":"Efficient RT-QuIC seeding activity for \u03b1-synuclein in olfactory mucosa samples of patients with Parkinson's disease and multiple system atrophy","volume":"8","author":"De Luca","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2025.102739_bib53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jnnp-2017-316605","article-title":"Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"89","author":"De Schaepdryver","year":"2018","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102739_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106986","article-title":"The role of AI and machine learning in the diagnosis of Parkinson's disease and atypical parkinsonisms","volume":"126","author":"Dennis","year":"2024","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102739_bib55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-8-39","article-title":"Heart fatty acid binding protein and A\u03b2-associated Alzheimer's neurodegeneration","volume":"8","author":"Desikan","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.102739_bib56","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30190-0","article-title":"The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Deuschl","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.arr.2025.102739_bib57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.msard.2012.01.002","article-title":"Urine: An under-studied source of biomarkers in multiple sclerosis?","volume":"1","author":"Dobson","year":"2012","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102739_bib58","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00401-021-02324-0","article-title":"\u03b1-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy","volume":"142","author":"Dutta","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2025.102739_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14301-3","article-title":"Exosomal microRNA signatures in multiple sclerosis reflect disease status","volume":"7","author":"Ebrahimkhani","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102739_bib60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.20517\/evcna.2023.13","article-title":"Synaptic proteins in neuron-derived extracellular vesicles as biomarkers for Alzheimer's disease: novel methodology and clinical proof of concept","volume":"4","author":"Eitan","year":"2023","journal-title":"Extra Vesicles Circ. Nucl. Acids"},{"key":"10.1016\/j.arr.2025.102739_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1281567","article-title":"The role of microRNAs involved in the disorder of blood-brain barrier in the pathogenesis of multiple sclerosis","volume":"14","author":"Emami Nejad","year":"2023","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2025.102739_bib62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00415-024-12732-3","article-title":"Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort","volume":"272","author":"Eratne","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib63","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2025.102739_bib64","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","article-title":"Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study","volume":"11","author":"Fiandaca","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102739_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010139","article-title":"The immune signature of csf in multiple sclerosis with and without oligoclonal bands: a machine learning approach to proximity extension assay analysis","volume":"25","author":"Gaetani","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib66","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102739_bib67","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102739_bib68","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.tips.2020.09.011","article-title":"CSF and blood biomarkers in neuroinflammatory and neurodegenerative diseases: implications for treatment","volume":"41","author":"Gaetani","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib69","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","article-title":"Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in definite subtypes of disease","volume":"74","author":"Gaiani","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/s43587-025-00818-0","article-title":"Large-scale proteomic analyses of incident Parkinson\u2019s disease reveal new pathophysiological insights and potential biomarkers","author":"Gan","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2025.102739_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.821499","article-title":"Personalized disease monitoring in pediatric onset multiple sclerosis using the saliva free light chain test","volume":"13","author":"Ganelin-Cohen","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.arr.2025.102739_bib72","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-024-02750-w","article-title":"Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer's disease","volume":"147","author":"Gao","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2025.102739_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai7866","article-title":"Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis","volume":"9","author":"Gendron","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2025.102739_bib74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032590","article-title":"Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer's Disease Correlated with Choroidal Thickness","volume":"24","author":"Gharbiya","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib75","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","article-title":"Plasma Concentration of the neurofilament light protein (NFL) is a Biomarker of CNS Injury in HIV infection: a cross-sectional study","volume":"3","author":"Gissl\u00e9n","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2025.102739_bib76","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/jamaneurol.2013.6064","article-title":"Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis","volume":"71","author":"Grossman","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib77","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/s41562-024-01924-6","article-title":"Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer's disease","volume":"8","author":"Guo","year":"2024","journal-title":"Nat. Hum. Behav."},{"key":"10.1016\/j.arr.2025.102739_bib78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneuroim.2011.02.009","article-title":"Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis: prospective clinical and MRI follow-up study","volume":"234","author":"Hagman","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.arr.2025.102739_bib79","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jnnp-2021-327129","article-title":"Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS","volume":"93","author":"Halbgebauer","year":"2022","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102739_bib80","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2025.102739_bib81","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.arr.2025.102739_bib82","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/brain\/awaa179","article-title":"Impaired glymphatic function and clearance of tau in an Alzheimer's disease model","volume":"143","author":"Harrison","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.102739_bib83","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41531-023-00505-0","article-title":"Serum but not cerebrospinal fluid levels of allantoin are increased in de novo Parkinson's disease","volume":"9","author":"Has\u00edkov\u00e1","year":"2023","journal-title":"NPJ Park. 'S. Dis."},{"key":"10.1016\/j.arr.2025.102739_bib84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-021-00249-y","article-title":"Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease","volume":"10","author":"He","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2025.102739_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104573","article-title":"Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study","volume":"91","author":"Hegen","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2025.102739_bib86","article-title":"Morphology-specific discrimination between ms white matter lesions and benign white matter hyperintensities using ultra-high-field MRI","author":"Hosseini","year":"2018","journal-title":"Ajnr. Am. J. Neuroradiol. 39, 1473-1479"},{"key":"10.1016\/j.arr.2025.102739_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111592","article-title":"Blood Transcript biomarkers selected by machine learning algorithm classify neurodegenerative diseases including Alzheimer's Disease","volume":"12","author":"Huseby","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2025.102739_bib88","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1093\/brain\/aww237","article-title":"Exosome secretion is a key pathway for clearance of pathological TDP-43","volume":"139","author":"Iguchi","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.102739_bib89","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","article-title":"A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS\u2013FTD","volume":"30","author":"Irwin","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2025.102739_bib90","doi-asserted-by":"crossref","first-page":"e1038","DOI":"10.1212\/WNL.0000000000005166","article-title":"CSF tau and \u03b2-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders","volume":"90","author":"Irwin","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102739_bib91","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/jnnp-2018-320151","article-title":"Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes","volume":"90","author":"Jabbari","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102739_bib92","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102739_bib93","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2025.102739_bib94","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","article-title":"Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 Assays in Alzheimer Disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib95","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding Alzheimer's disease","volume":"390","author":"Jia","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2025.102739_bib96","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/brain\/awad267","article-title":"The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease","volume":"147","author":"Jung","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.102739_bib97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13195-022-01011-w","article-title":"Diagnostic value of serum versus plasma phospho-tau for Alzheimer\u2019s disease","volume":"14","author":"Kac","year":"2022","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102739_bib98","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","article-title":"The immunobiology of MIF: function, genetics and prospects for precision medicine","volume":"15","author":"Kang","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.arr.2025.102739_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.966139","article-title":"Editorial: blood biomarkers of neurodegenerative diseases","volume":"15","author":"Karikari","year":"2022","journal-title":"Front Mol. Neurosci."},{"key":"10.1016\/j.arr.2025.102739_bib100","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/acn3.50943","article-title":"Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS","volume":"6","author":"Kasai","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713429","article-title":"Tear biomarkers and Alzheimer's disease","volume":"24","author":"Ka\u0161telan","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib102","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13195-021-00907-3","article-title":"Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer's disease, Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy","volume":"13","author":"Katayama","year":"2021","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102739_bib103","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib104","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00415-023-12081-7","article-title":"The elusive nature of the oligoclonal bands in multiple sclerosis","volume":"271","author":"Kennedy","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders \u2014 towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib106","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41582-020-00434-z","article-title":"Improving clinical trial outcomes in amyotrophic lateral sclerosis","volume":"17","author":"Kiernan","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib107","article-title":"Adiponectin: the potential regulator and therapeutic target of obesity and Alzheimer's Disease","volume":"21","author":"Kim","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib108","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuron.2020.08.022","article-title":"ALS Genetics: gains, losses, and implications for future therapies","volume":"108","author":"Kim","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2025.102739_bib109","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41598-024-51334-x","article-title":"Clinical evaluation of a novel plasma pTau217 electrochemiluminescence immunoassay in Alzheimer's disease","volume":"14","author":"Kivis\u00e4kk","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102739_bib110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molmed.2012.10.008","article-title":"Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis","volume":"19","author":"Koch","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.arr.2025.102739_bib111","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41591-021-01615-z","article-title":"Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis","volume":"28","author":"Korobeynikov","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2025.102739_bib112","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1007\/s12035-022-03187-6","article-title":"Saliva and serum acetylcholinesterase activity in multiple sclerosis","volume":"60","author":"Koshkzari","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102739_bib113","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/s41467-022-30387-4","article-title":"Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS\/FTD","volume":"13","author":"Krishnan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2025.102739_bib114","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102739_bib115","doi-asserted-by":"crossref","first-page":"13815","DOI":"10.1039\/D2SC00066K","article-title":"An antibody scanning method for the detection of \u03b1-synuclein oligomers in the serum of Parkinson's disease patients","volume":"13","author":"Kulenkampff","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib116","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/jnnp-2022-330048","article-title":"Prognostic biomarkers in prodromal alpha-synucleinopathies: DAT binding and REM sleep without atonia","volume":"94","author":"Kunz","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102739_bib117","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/jnnp-2022-330048","article-title":"Prognostic biomarkers in prodromal \u03b1-synucleinopathies: DAT binding and REM sleep without atonia","volume":"94","author":"Kunz","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102739_bib118","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1373\/clinchem.2008.104497","article-title":"The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients","volume":"54","author":"Lee","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.arr.2025.102739_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102725","article-title":"Robust and interpretable AI-guided marker for early dementia prediction in real-world clinical settings","volume":"74","author":"Lee","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.arr.2025.102739_bib120","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/mds.28288","article-title":"The nosology of lewy body disorders from analytic-epidemiologic and statistical vantage points","volume":"35","author":"Levy","year":"2020","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.arr.2025.102739_bib121","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.chemosphere.2019.05.064","article-title":"Identification of miRNA-7 as a regulator of brain-derived neurotrophic factor\/\u4f2a-synuclein axis in atrazine-induced Parkinson's disease by peripheral blood and brain microRNA profiling","volume":"233","author":"Li","year":"2019","journal-title":"Chemosphere"},{"key":"10.1016\/j.arr.2025.102739_bib122","doi-asserted-by":"crossref","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","article-title":"Blood NfL: A biomarker for disease severity and progression in Parkinson disease","volume":"93","author":"Lin","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102739_bib123","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.aab0983","article-title":"TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD","volume":"349","author":"Ling","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.arr.2025.102739_bib124","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","article-title":"DLB and PDD boundary issues","volume":"68","author":"Lippa","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102739_bib125","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41598-017-16927-9","article-title":"Cytokine MIF enhances blood-brain barrier permeability: impact for therapy in ischemic stroke","volume":"8","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102739_bib126","doi-asserted-by":"crossref","first-page":"22999","DOI":"10.1021\/acsnano.3c08456","article-title":"Single-molecule detection of \u03b1-synuclein oligomers in Parkinson's disease patients using nanopores","volume":"17","author":"Liu","year":"2023","journal-title":"ACS nano"},{"key":"10.1016\/j.arr.2025.102739_bib127","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fnagi.2017.00289","article-title":"Cerebrospinal fluid biomarkers of Alzheimer's disease show different but partially overlapping profile compared to vascular dementia","volume":"9","author":"Llorens","year":"2017","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102739_bib128","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102739_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139233","article-title":"Plasma Exosomal miRNAs in persons with and without Alzheimer disease: altered expression and prospects for biomarkers","volume":"10","author":"Lugli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2025.102739_bib130","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1007\/s00415-020-10047-7","article-title":"Urinary neopterin, a new marker of the neuroinflammatory status in amyotrophic lateral sclerosis","volume":"267","author":"Lunetta","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib131","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41594-022-00837-0","article-title":"Global, in situ analysis of the structural proteome in individuals with Parkinson's disease to identify a new class of biomarker","volume":"29","author":"Mackmull","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.arr.2025.102739_bib132","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41593-021-00936-z","article-title":"Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis","volume":"24","author":"Magen","year":"2021","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2025.102739_bib133","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/mds.28611","article-title":"Cerebrospinal \u03b1-synuclein oligomers reflect disease motor severity in DeNoPa longitudinal cohort","volume":"36","author":"Majbour","year":"2021","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.arr.2025.102739_bib134","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12883-018-1091-7","article-title":"TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"18","author":"Majumder","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib135","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1001\/jama.2022.14236","article-title":"What is multiple sclerosis?","volume":"328","author":"Marcus","year":"2022","journal-title":"Jama"},{"key":"10.1016\/j.arr.2025.102739_bib136","doi-asserted-by":"crossref","first-page":"e1479","DOI":"10.1212\/WNL.0000000000007179","article-title":"Serum NFL discriminates Parkinson disease from atypical parkinsonisms","volume":"92","author":"Marques","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102739_bib137","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00726-021-03111-7","article-title":"Multiple sclerosis and myelin basic protein: insights into protein disorder and disease","volume":"54","author":"Martinsen","year":"2022","journal-title":"Amino Acids"},{"key":"10.1016\/j.arr.2025.102739_bib138","doi-asserted-by":"crossref","first-page":"5970","DOI":"10.1002\/alz.13479","article-title":"Artificial intelligence for neurodegenerative experimental models","volume":"19","author":"Marzi","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102739_bib139","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41582-023-00891-2","article-title":"Biomarkers in amyotrophic lateral sclerosis: current status and future prospects","volume":"19","author":"McMackin","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation","volume":"22","author":"Mead","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2025.102739_bib141","first-page":"1797","article-title":"Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer's disease","volume":"28","author":"Mil\u00e0-Alom\u00e0","year":"2022","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2025.102739_bib142","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/alz.12131","article-title":"Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum","volume":"16","author":"Mil\u00e0-Alom\u00e0","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102739_bib143","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2025.102739_bib144","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1742-2094-4-16","article-title":"Saliva soluble HLA as a potential marker of response to interferon-beta 1a in multiple sclerosis: a preliminary study","volume":"4","author":"Minagar","year":"2007","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102739_bib145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/01.wnl.0000333251.36681.a5","article-title":"A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis","volume":"72","author":"Mitchell","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102739_bib146","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147641","article-title":"Long non-coding RNAs and Alzheimer's disease: towards personalized diagnosis","volume":"25","author":"Mosquera-Heredia","year":"2024","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib147","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-024-00705-z","article-title":"CSF protein ratios with enhanced potential to reflect Alzheimer's disease pathology and neurodegeneration","volume":"19","author":"Mravinacov\u00e1","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.102739_bib148","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","article-title":"Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis","volume":"296","author":"Munger","year":"2006","journal-title":"Jama"},{"key":"10.1016\/j.arr.2025.102739_bib149","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/mds.29287","article-title":"Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders","volume":"38","author":"Nilsson","year":"2023","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.arr.2025.102739_bib150","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1352458516639384","article-title":"Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis","volume":"23","author":"Novakova","year":"2017","journal-title":"Mult. Scler. (Houndmills, Basingstoke, Engl. )"},{"key":"10.1016\/j.arr.2025.102739_bib151","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","article-title":"Monitoring disease activity in multiple sclerosis using serum neurofilament light protein","volume":"89","author":"Novakova","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102739_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110651","article-title":"Uptake, functionality, and re-release of extracellular vesicle-encapsulated cargo","volume":"39","author":"O\u2019Brien","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.arr.2025.102739_bib153","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2169\/internalmedicine.47.1278","article-title":"Salivary chromogranin a: useful and quantitative biochemical marker of affective state in patients with amyotrophic lateral sclerosis","volume":"47","author":"Obayashi","year":"2008","journal-title":"Intern. Med."},{"key":"10.1016\/j.arr.2025.102739_bib154","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jnnp-2018-318868","article-title":"Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase","volume":"90","author":"Oeckl","year":"2019","journal-title":"J. Neurol., Neurosurg. amp; Psychiatry"},{"key":"10.1016\/j.arr.2025.102739_bib155","doi-asserted-by":"crossref","DOI":"10.7326\/AITC202106150","article-title":"Multiple Sclerosis","volume":"174","author":"Olek","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.arr.2025.102739_bib156","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib157","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib158","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adc9778","article-title":"A single-cell analysis framework allows for characterization of CSF leukocytes and their tissue of origin in multiple sclerosis","volume":"14","author":"Ostkamp","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2025.102739_bib159","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13195-018-0361-3","article-title":"Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic","volume":"10","author":"Paterson","year":"2018","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102739_bib160","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae187","article-title":"Converging peripheral blood microRNA profiles in Parkinson's disease and progressive supranuclear palsy","volume":"6","author":"Pavelka","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2025.102739_bib161","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","article-title":"Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease","volume":"88","author":"Poesen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102739_bib162","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-021-00232-4","article-title":"Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes","volume":"7","author":"Quadalti","year":"2021","journal-title":"npj Park. 'S. Dis."},{"key":"10.1016\/j.arr.2025.102739_bib163","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s43587-023-00410-4","article-title":"Detection and treatment of Alzheimer's disease in its preclinical stage","volume":"3","author":"Rafii","year":"2023","journal-title":"Nat. Aging"},{"key":"10.1016\/j.arr.2025.102739_bib164","first-page":"1351","article-title":"Screening for Alzheimer\u2019s Disease Using Saliva: A New Approach Based on Machine Learning and Raman Hyperspectroscopy","volume":"71","author":"Ralbovsky","year":"2019"},{"key":"10.1016\/j.arr.2025.102739_bib165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13023-022-02187-y","article-title":"Neuroradiological differentiation of white matter lesions in patients with multiple sclerosis and Fabry disease","volume":"17","author":"Rath","year":"2022","journal-title":"Orphanet J. rare Dis."},{"key":"10.1016\/j.arr.2025.102739_bib166","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae271","article-title":"Increased CXCL12, a potential CSF biomarker for differential diagnosis of amyotrophic lateral sclerosis","author":"Roca-Pereira","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.arr.2025.102739_bib167","series-title":"Elecsys\u00ae Phospho-Tau (181P) CSF: Robust and Accurate Biomarker Tests To Aid Clinical Decisions","author":"Roche_Diagnostics","year":"2025"},{"key":"10.1016\/j.arr.2025.102739_bib168","series-title":"Elecsys\u00ae \u03b2-Amyloid (1-42) CSF II: Robust and Accurate Biomarker Tests To Aid Clinical Decisions","author":"Roche_Diagnostics","year":"2025"},{"key":"10.1016\/j.arr.2025.102739_bib169","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.psyneuen.2011.04.013","article-title":"The cortisol awakening response in amyotrophic lateral sclerosis is blunted and correlates with clinical status and depressive mood","volume":"37","author":"Roozendaal","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.arr.2025.102739_bib170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-8-20","article-title":"Fluid biomarkers in Alzheimer's disease - current concepts","volume":"8","author":"Ros\u00e9n","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.102739_bib171","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13195-019-0557-1","article-title":"Progression to dementia in memory clinic patients with mild cognitive impairment and normal \u03b2-amyloid","volume":"11","author":"Rosenberg","year":"2019","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102739_bib172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12031-011-9665-5","article-title":"CSF Biomarkers for amyloid and tau pathology in Alzheimer's Disease","volume":"47","author":"Rosenmann","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.arr.2025.102739_bib173","doi-asserted-by":"crossref","first-page":"110603","DOI":"10.1016\/j.clinbiochem.2023.110603","article-title":"The microRNA-485-3p concentration in salivary exosome-enriched extracellular vesicles is related to amyloid \u03b2 deposition in the brain of patients with Alzheimer\u2019s disease","volume":"118","author":"Ryu","year":"2023","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/j.arr.2025.102739_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082448","article-title":"The first dose of fingolimod affects circulating extracellular vesicles in multiple sclerosis patients","volume":"19","author":"S\u00e1enz-Cuesta","year":"2018","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib175","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1007\/s12035-023-03470-0","article-title":"Evaluation of long non-coding RNA expression profiles in peripheral blood mononuclear cells of patients with Parkinson\u2019s Disease","volume":"60","author":"Sar\u0131ekiz","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102739_bib176","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.brainres.2018.12.016","article-title":"Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients","volume":"1708","author":"Saucier","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2025.102739_bib177","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.arr.2025.102739_bib178","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41591-024-02985-w","article-title":"Molecular pathology markers of FTD and ALS in blood extracellular vesicles","volume":"30","author":"Schneider","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2025.102739_bib179","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/embj.201386609","article-title":"The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus","volume":"33","author":"Schwartz","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.arr.2025.102739_bib180","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1007\/s00415-022-11507-y","article-title":"Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis","volume":"270","author":"Sen","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib181","first-page":"645","article-title":"Overexpression of blood microRNAs 103a, 30b, and 29a in l-dopa\u2013treated patients with PD","volume":"84","author":"Serafin","year":"2015"},{"key":"10.1016\/j.arr.2025.102739_bib182","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","article-title":"Discriminating \u03b1-synuclein strains in Parkinson's disease and multiple system atrophy","volume":"578","author":"Shahnawaz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.arr.2025.102739_bib183","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-023-00339-z","article-title":"Employing nanoparticle tracking analysis of salivary neuronal exosomes for early detection of neurodegenerative diseases","volume":"12","author":"Sharma","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2025.102739_bib184","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087398","article-title":"The extracellular domain of neurotrophin receptor p75 as a candidate biomarker for amyotrophic lateral sclerosis","volume":"9","author":"Shepheard","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.arr.2025.102739_bib185","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/ene.15237","article-title":"Urinary neopterin: a novel biomarker of disease progression in amyotrophic lateral sclerosis","volume":"29","author":"Shepheard","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib186","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1212\/WNL.0000000000003741","article-title":"Urinary p75ECD","volume":"88","author":"Shepheard","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102739_bib187","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2011.10.045","article-title":"Tetranor PGDM analyses for the amyotrophic lateral sclerosis: positive and simple diagnosis and evaluation of drug effect","volume":"415","author":"Shinozawa","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2025.102739_bib188","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk3674","article-title":"CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly","volume":"10","author":"Shue","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.arr.2025.102739_bib189","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.conb.2019.11.019","article-title":"An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead","volume":"61","author":"Simren","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.arr.2025.102739_bib190","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1021\/pr501162w","article-title":"Proteomics urine analysis of pregnant women suffering from multiple sclerosis","volume":"14","author":"Singh","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.arr.2025.102739_bib191","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbrc.2022.04.127","article-title":"A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker candidates","volume":"613","author":"Sjoqvist","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.arr.2025.102739_bib192","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.3390\/ijms24065237","article-title":"Saliva and saliva extracellular vesicles for biomarker candidate identification\u2014assay development and pilot study in amyotrophic lateral sclerosis","volume":"24","author":"Sjoqvist","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib193","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41368-022-00209-w","article-title":"Promising applications of human-derived saliva biomarker testing in clinical diagnostics","volume":"15","author":"Song","year":"2023","journal-title":"Int. J. Oral. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib194","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/mds.29171","article-title":"Serum MicroRNAs predict isolated rapid eye movement sleep behavior disorder and lewy body diseases","volume":"37","author":"Soto","year":"2022","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.arr.2025.102739_bib195","first-page":"12","article-title":"Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients","volume":"87","author":"Steinacker","year":"2016","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102739_bib196","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12974-022-02667-9","article-title":"Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-na\u00efve multiple sclerosis","volume":"19","author":"Straeten","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102739_bib197","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000505851","article-title":"A pilot study of urinary exosomes in Alzheimer's disease","volume":"19","author":"Sun","year":"2019","journal-title":"Neuro-Degener. Dis."},{"key":"10.1016\/j.arr.2025.102739_bib198","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12967-019-1909-0","article-title":"ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia","volume":"17","author":"Swindell","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.arr.2025.102739_bib199","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.artmed.2023.102588","article-title":"Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: a systematic review","volume":"142","author":"Tavazzi","year":"2023","journal-title":"Artif. Intell. Med."},{"key":"10.1016\/j.arr.2025.102739_bib201","doi-asserted-by":"crossref","first-page":"22894","DOI":"10.1073\/pnas.1917054116","article-title":"Breakthroughs in antemortem diagnosis of neurodegenerative diseases","volume":"116","author":"Telling","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2025.102739_bib202","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","article-title":"Biomarker-based staging of Alzheimer disease: rationale and clinical applications","volume":"20","author":"Therriault","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib203","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamaneurol.2022.4485","article-title":"Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography","volume":"80","author":"Therriault","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib204","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrneurol.2016.68","article-title":"Extracellular vesicles in neurodegenerative disease \u2014 pathogenesis to biomarkers","volume":"12","author":"Thompson","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib205","doi-asserted-by":"crossref","DOI":"10.3390\/s23115251","article-title":"Experimental analysis of tear fluid and its processing for the diagnosis of multiple sclerosis","volume":"23","author":"Tome\u010dkov\u00e1","year":"2023","journal-title":"Sensors"},{"key":"10.1016\/j.arr.2025.102739_bib206","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14442","article-title":"Plasma A\u5c3e(42)\/A\u5c3e(40) is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum","volume":"21","author":"Trelle","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102739_bib207","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bcp.2017.12.020","article-title":"Microglia-derived extracellular vesicles in Alzheimer's Disease: a double-edged sword","volume":"148","author":"Trotta","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2025.102739_bib208","first-page":"90","article-title":"Metabolome of canine and human saliva: a non-targeted metabolomics study","volume":"16","author":"Turunen","year":"2020","journal-title":"Metab.: Off. J. Metab. Soc."},{"key":"10.1016\/j.arr.2025.102739_bib209","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2020.04.017","article-title":"Astrocyte-derived extracellular vesicles: neuroreparative properties and role in the pathogenesis of neurodegenerative disorders","volume":"323","author":"Upadhya","year":"2020","journal-title":"J. Control. Release: Off. J. Control. Release Soc."},{"key":"10.1016\/j.arr.2025.102739_bib210","article-title":"Immune profiling of plasma-derived extracellular vesicles identifies Parkinson disease","volume":"7","author":"Vacchi","year":"2020","journal-title":"Neurol. (R. ) Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102739_bib211","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41582-021-00487-8","article-title":"Non-neuronal cells in amyotrophic lateral sclerosis \u2014 from pathogenesis to biomarkers","volume":"17","author":"Vahsen","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib212","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40035-019-0178-4","article-title":"Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in","volume":"8","author":"Van Schependom","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2025.102739_bib213","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/acn3.51708","article-title":"Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis","volume":"10","author":"Verde","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib214","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde","year":"2019","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2025.102739_bib215","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.23627","article-title":"Myeloid microvesicles are a marker and therapeutic target for neuroinflammation","volume":"72","author":"Verderio","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib216","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12967-025-06148-4","article-title":"Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approach","volume":"23","author":"Vignoli","year":"2025","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.arr.2025.102739_bib217","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s13311-017-0562-7","article-title":"Pregnancy: effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding","volume":"14","author":"Voskuhl","year":"2017","journal-title":"Neurother.: J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.arr.2025.102739_bib218","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2019.06.021","article-title":"Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic disease","volume":"45","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.arr.2025.102739_bib219","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1273807","article-title":"Urine metabolomics phenotyping and urinary biomarker exploratory in mild cognitive impairment and Alzheimer's disease","volume":"15","author":"Wang","year":"2023","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102739_bib220","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13195-023-01324-4","article-title":"Identification of novel diagnostic panel for mild cognitive impairment and Alzheimer's disease: findings based on urine proteomics and machine learning","volume":"15","author":"Wang","year":"2023","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102739_bib221","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23821","article-title":"Association of cerebrospinal fluid neurofilament heavy protein levels with clinical progression in patients with Parkinson Disease","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.arr.2025.102739_bib222","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib223","first-page":"54","article-title":"Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions","volume":"28","author":"Wattjes","year":"2007","journal-title":"Ajnr. Am. J. Neuroradiol."},{"key":"10.1016\/j.arr.2025.102739_bib224","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12883-019-1591-0","article-title":"Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease","volume":"20","author":"Wattmo","year":"2020","journal-title":"BMC Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib225","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","article-title":"Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease","volume":"7","author":"Whelan","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2025.102739_bib226","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-020-00741-z","article-title":"Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer's disease","volume":"13","author":"Whiley","year":"2021","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102739_bib227","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/135245859800400105","article-title":"Myelin basic protein in cerebrospinal fluid and other body fluids","volume":"4","author":"Whitaker","year":"1998","journal-title":"Mult. Scler. (Houndmills, Basingstoke, Engl. )"},{"key":"10.1016\/j.arr.2025.102739_bib228","article-title":"Assessing neurofilaments as biomarkers of neuroprotection in progressive multiple sclerosis: from the MS-STAT randomized controlled trial","volume":"9","author":"Williams","year":"2022","journal-title":"Neurol. (R. ) Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.arr.2025.102739_bib229","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1002\/alz.13390","article-title":"Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia","volume":"19","author":"Winchester","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102739_bib230","first-page":"892","article-title":"Neuronal FAM171A2 mediates \u03b1-synuclein fibril uptake and drives Parkinson\u2019s disease","volume":"387","author":"Wu","year":"2025"},{"key":"10.1016\/j.arr.2025.102739_bib231","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40035-023-00364-y","article-title":"Brain metabolism in Alzheimer's disease: biological mechanisms of exercise","volume":"12","author":"Xu","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2025.102739_bib232","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202207107","article-title":"Engineered extracellular vesicles with shp2 high expression promote mitophagy for Alzheimer's disease treatment","volume":"34","author":"Xu","year":"2022","journal-title":"Adv. Mater. (Deerfield Beach, Fla. )"},{"key":"10.1016\/j.arr.2025.102739_bib233","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1002\/alz.13318","article-title":"Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease","volume":"19","author":"Yakoub","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102739_bib234","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14537","article-title":"Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window","volume":"21","author":"Yakoub","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102739_bib235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jamaneurol.2023.4398","article-title":"Neuronally derived extracellular vesicle \u03b1-synuclein as a serum biomarker for individuals at risk of developing Parkinson disease","volume":"81","author":"Yan","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib236","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03456-9","article-title":"Salivary gland dysfunction and salivary redox imbalance in patients with Alzheimer's disease","volume":"11","author":"Zalewska","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102739_bib237","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13195-022-01004-9","article-title":"Cerebrospinal fluid lactate levels along the Alzheimer's disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers","volume":"14","author":"Zebhauser","year":"2022","journal-title":"Alzheimer'S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102739_bib238","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s13167-021-00265-y","article-title":"Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine","volume":"12","author":"Zhan","year":"2021","journal-title":"EPMA J."},{"key":"10.1016\/j.arr.2025.102739_bib239","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113895","article-title":"Exosomes derived from bone marrow mesenchymal stromal cells promote remyelination and reduce neuroinflammation in the demyelinating central nervous system","volume":"347","author":"Zhang","year":"2022","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2025.102739_bib240","article-title":"Corticotropin-releasing factor receptor-1 modulates biomarkers of DNA oxidation in Alzheimer's disease mice","volume":"12","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2025.102739_bib241","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10571-014-0068-3","article-title":"Abnormal expression of synaptophysin, SNAP-25, and synaptotagmin 1 in the hippocampus of kainic acid-exposed rats with behavioral deficits","volume":"34","author":"Zhang","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102739_bib242","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12902-019-0402-3","article-title":"Relationship between inflammatory markers and mild cognitive impairment in Chinese patients with type 2 diabetes: a case-control study","volume":"19","author":"Zheng","year":"2019","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.arr.2025.102739_bib243","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41398-023-02683-0","article-title":"Peripheral immunity and risk of incident brain disorders: a prospective cohort study of 161,968 participants","volume":"13","author":"Zhong","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2025.102739_bib244","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13745","article-title":"N-homocysteinylation of \u03b1-synuclein promotes its aggregation and neurotoxicity","volume":"22","author":"Zhou","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2025.102739_bib245","first-page":"24","article-title":"iTRAQ-based proteomic analysis of APP transgenic mouse urine exosomes","author":"Zhou","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102739_bib246","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s13311-020-00842-5","article-title":"Long noncoding RNA POU3F3 and \u03b1-Synuclein in plasma L1CAM exosomes combined with \u03b2-glucocerebrosidase activity: potential predictors of Parkinson's Disease","volume":"17","author":"Zou","year":"2020","journal-title":"Neurother.: J. Am. Soc. Exp. Neurother."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725000856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725000856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T09:11:19Z","timestamp":1761642679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163725000856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":246,"alternative-id":["S1568163725000856"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2025.102739","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluid-based biomarkers for neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2025.102739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102739"}}